Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 25 (2014), Issue 4, Pages 211-216
http://dx.doi.org/10.1155/2014/237560
Original Article

Safety and Immunogenicity of Two Doses of Quadrivalent Meningococcal Conjugate Vaccine or One Dose of Meningococcal Group C Conjugate Vaccine, both Administered Concomitantly with Routine Immunization to 12- to 18-Month-Old Children

Francisco Noya,1 Deirdre McCormack,1 Donna L Reynolds,2 Dion Neame,2 and Philipp Oster3

1Montreal Children’s Hospital – McGill University Health Centre, Montreal, Quebec, Canada
2Sanofi Pasteur Ltd, Toronto, Ontario, Canada
3Sanofi Pasteur, Lyon, France

Copyright © 2014 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Francisco Noya, Deirdre McCormack, Donna L Reynolds, Dion Neame, and Philipp Oster, “Safety and Immunogenicity of Two Doses of Quadrivalent Meningococcal Conjugate Vaccine or One Dose of Meningococcal Group C Conjugate Vaccine, both Administered Concomitantly with Routine Immunization to 12- to 18-Month-Old Children,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 25, no. 4, pp. 211-216, 2014. doi:10.1155/2014/237560